This is consistent with the rarity of ARID1A missense mutations compared to nonsense mutations and frameshifts in other cancer types, suggesting that missense mutations are not selected for in general due to their lack of an effect on downstream processes [39, 40]. The gene discussed is ARID1A; the disease is cancer.